Skip to main content
    H

    Hologic Inc (HOLX)

    Official site

    MEDICAL INSTRUMENTS & SUPPLIES

    $76.01
    +0.00 (+0.00%)

    Last updated: Apr 07, 2026 at 5:00 PM ET

    Hologic Inc (HOLX) Financials: Revenue, Profit and Cash Flow

    Updated Jan 29, 2026. Financial statements from company filings, amounts in US dollars.

    Hologic reported revenue of $4.10B for the fiscal year ended Sep 30, 2025, up 1.7% from the year before. That year, net income was $565.70M with a net margin of 13.8%, operating cash flow was $1.06B and free cash flow was $920.10M. The quarter ended Dec 31, 2025 had revenue of $1.05B and net income of $179.10M.

    Revenue and Margins

    The operating margin was 17.4% in the fiscal year ended Sep 2025. Over the 9 years to Sep 2025, revenue grew from $2.83B, a compound annual rate of 4.2%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Sep 2025$4.10B+1.7%51.6%17.4%13.8%
    Sep 2024$4.03B0.0%55.3%21.9%19.6%
    Sep 2023$4.03B-17.1%51.4%16.6%11.3%
    Sep 2022$4.86B-13.7%61.6%33.7%26.8%
    Sep 2021$5.63B+49.1%67.4%44.0%33.2%
    Sep 2020$3.78B+12.1%59.0%29.3%29.4%
    Sep 2019$3.37B+4.6%34.8%-3.7%-6.0%
    Sep 2018$3.22B+5.2%52.7%-7.4%-3.5%
    Sep 2017$3.06B+8.0%53.0%44.8%24.7%
    Sep 2016$2.83BN/A55.2%19.4%11.7%
    Annual, fiscal years ended Sep 2016 to Sep 2025

    Income Statement

    In the fiscal year ended Sep 2025, net income fell 28.3% from the year before. In the quarter ended Dec 2025, net income fell 10.9% from the same quarter a year earlier.

    Annual

    Line itemSep 2025Sep 2024Sep 2023Sep 2022Sep 2021Sep 2020Sep 2019Sep 2018Sep 2017Sep 2016
    Revenue$4.10B$4.03B$4.03B$4.86B$5.63B$3.78B$3.37B$3.22B$3.06B$2.83B
    Cost of revenue$1.98B$1.80B$1.96B$1.87B$1.84B$1.55B$2.20B$1.52B$1.44B$1.07B
    Gross profit$2.12B$2.23B$2.07B$3.00B$3.80B$2.23B$1.17B$1.70B$1.62B$1.56B
    Research and development$248.20M$272.80M$294.30M$283.40M$276.30M$222.50M$232.20M$218.70M$232.80M$232.10M
    Operating income$714.30M$882.60M$668.40M$1.64B$2.48B$1.10B-$123.80M-$237.90M$1.37B$548.60M
    Net income$565.70M$789.50M$456.00M$1.30B$1.87B$1.11B-$203.60M-$111.30M$755.50M$330.80M
    EBITDA$1.02B$1.19B$990.10M$2.10B$2.88B$1.49B$342.40M$250.00M$1.88B$1.09B
    Fiscal years ended Sep 2016 to Sep 2025

    Quarterly

    Line itemDec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Revenue$1.05B$1.05B$1.02B$1.01B$1.02B$988.00M$1.01B$1.02B$1.01B$945.30M$984.40M$1.03B
    Gross profit$586.40M$583.50M$576.60M$377.30M$580.50M$557.70M$560.30M$542.30M$567.50M$500.30M$367.50M$585.80M
    Operating income$237.00M$236.90M$254.60M-$7.00M$229.80M$230.00M$244.00M$210.40M$198.20M$132.50M$1.40M$272.10M
    Net income$179.10M$187.20M$194.90M-$17.40M$201.00M$178.60M$194.50M$169.90M$246.50M$90.60M-$40.50M$218.50M
    Last 12 quarters

    Balance Sheet

    As of Sep 2025, total debt of $2.51B exceeded cash and equivalents by $548.40M.

    Annual

    Line itemSep 2025Sep 2024Sep 2023Sep 2022Sep 2021Sep 2020Sep 2019Sep 2018Sep 2017Sep 2016
    Total assets$9.01B$9.16B$9.14B$9.07B$8.92B$7.20B$6.44B$7.23B$7.98B$7.32B
    Current assets$3.67B$3.82B$4.18B$3.86B$3.17B$2.22B$1.79B$1.72B$1.48B$1.33B
    Cash and equivalents$1.96B$2.16B$2.72B$0$0$701.00M$601.80M$666.70M$540.60M$548.40M
    Total liabilities$3.97B$4.03B$4.12B$4.20B$4.70B$4.49B$4.33B$4.80B$5.19B$5.17B
    Short-term debt$2.90M$37.50M$287.00M$15.00M$313.00M$324.90M$273.20M$601.40M$1.15B$296.00M
    Long-term debt$2.50B$2.50B$2.53B$2.81B$2.71B$2.71B$2.78B$2.70B$2.17B$3.05B
    Shareholder equity$5.05B$5.13B$5.02B$4.88B$4.22B$2.71B$2.12B$2.43B$2.78B$2.14B
    Fiscal years ended Sep 2016 to Sep 2025

    Quarterly

    Line itemDec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Total assets$9.18B$9.01B$8.81B$8.55B$8.73B$9.16B$8.89B$8.71B$8.47B$9.14B$9.34B$9.45B
    Total liabilities$3.94B$3.97B$3.96B$3.93B$3.96B$4.03B$3.94B$3.87B$3.82B$4.12B$4.16B$4.15B
    Cash and equivalents$2.17B$1.96B$1.74B$1.43B$1.78B$2.16B$2.44B$2.18B$1.93B$2.72B$2.77B$2.58B
    Shareholder equity$5.25B$5.05B$4.84B$4.62B$4.77B$5.13B$4.95B$4.84B$4.65B$5.02B$5.18B$5.30B
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Sep 2025, free cash flow was 86.8% of operating cash flow. Share repurchases came to 81.8% of it.

    Annual

    Line itemSep 2025Sep 2024Sep 2023Sep 2022Sep 2021Sep 2020Sep 2019Sep 2018Sep 2017Sep 2016
    Operating cash flow$1.06B$1.29B$1.05B$2.13B$2.33B$896.60M$649.50M$732.90M$8.30M$798.20M
    Capital expenditures$137.00M$130.20M$150.20M$127.20M$177.70M$156.40M$109.10M$105.60M$107.60M$94.50M
    Free cash flow$920.10M$1.16B$901.00M$2.00B$2.15B$740.20M$540.40M$627.30M-$99.30M$703.70M
    Dividends paidN/AN/AN/AN/A$8.50M$1.80M$0$0$393.00M$250.00M
    Share repurchases$752.90M$835.10M$474.80M$542.10M$409.80M$653.60M$200.10M$275.80M$200.10M$250.00M
    Investing cash flow-$482.70M-$781.00M-$152.10M-$206.30M-$1.33B-$141.60M-$280.70M-$195.20M$285.80M-$68.40M
    Financing cash flow-$777.20M-$1.11B-$483.20M-$756.00M-$529.80M-$659.90M-$431.50M-$404.80M-$309.20M-$670.70M
    Fiscal years ended Sep 2016 to Sep 2025

    Quarterly

    Line itemDec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Operating cash flow$229.90M$355.10M$343.30M$169.40M$189.30M$367.00M$405.80M$292.40M$220.00M$258.70M$332.80M$206.30M
    Capital expenditures$35.10M$30.40M$34.80M$40.20M$31.60M$30.30M$33.90M$28.00M$38.00M$52.50M$36.50M$32.10M
    Free cash flow$194.80M$324.70M$308.50M$129.20M$157.70M$336.70M$371.90M$264.40M$182.00M$206.20M$296.30M$174.20M
    Last 12 quarters

    Frequently Asked Questions About HOLX

    What is Hologic's annual revenue?

    Hologic reported revenue of $4.10B for the fiscal year ended Sep 30, 2025.

    How fast is Hologic's revenue growing?

    Revenue was up 1.7% for the fiscal year ended Sep 30, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -5.5%.

    Is Hologic profitable?

    Yes. Hologic reported net income of $565.70M for the fiscal year ended Sep 30, 2025, with a net margin of 13.8%.

    How much free cash flow does HOLX generate?

    For the fiscal year ended Sep 30, 2025, operating cash flow of $1.06B minus capital expenditures of $137.00M produced free cash flow of $920.10M.

    How much debt does Hologic have?

    The balance sheet dated Sep 30, 2025 reported long-term debt of $2.50B, short-term debt of $2.90M and cash and equivalents of $1.96B.